The European Medicines Agency plays a central role in the regulation of Europe’s medicines supply. The Coronavirus pandemic has led the EU to expand and strengthen the EMA’s powers in pharmaceutical policy. This is happening against the backdrop of globalization, where the EMA is both influenced by and impacting on pharmaceutical policy far beyond its borders. This seminar unpacks and discusses these issues from the perspective of law and governance.

Moderated by Ms. Pramiti Parwani, Law Centre for Health and Life, University of Amsterdam

Speakers

Dr. Katrina Perehudoff, Senior Research Fellow, Law Centre for Health and Life, University of Amsterdam

Dr. Sabrina Röttger-Wirtz, Assistant Professor of EU Law, Faculty of Law, Maastricht University

Mr. Martin Harvey Allchurch, Head of International Affairs, European Medicines Agency

Ms. Ancella Santos Quintano, Senior Health Policy Officer, The European Consumers Organisation

Dr. Elena Petelos, Vice President HTA, EUPHA and Co-Chair RWE & AI, HTAi

This event is organised by the University of Amsterdam's Law Centre for Health and Life, the Amsterdam Centre for European Law and Governance, and the Amsterdam Centre for European Studies; the Amsterdam Institute for Global Health and Development; and the European Public Health Association sections on 'Law and Public Health' and on 'Health Technology Assessment'.